Human Genome Sciences Inc. - Clinical Immunology

LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta, in a defeat for rival drugmaker Eli Lilly.The UK Supreme Court ruling chimes with similar ...

LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar" class="inform">dollar sales expectations for its makers.The companies said the European Medicines Agency had ...

CHICAGO (Reuters) - Aiden Gallagher started developing symptoms of lupus at age 11 after a spider bite that left her hand swollen for weeks.Gallagher, now 18, took strong doses of the steroid prednisone to help control the disease, in which the immune ...

WASHINGTON (Reuters) - Human Genome Sciences Inc's lupus drug is poised to win clearance this week, offering patients the first approved treatment option in a half-century and setting the company up for blockbuster sales.Industry analysts widely expect Benlysta, one the most closely ...

WASHINGTON (Reuters) - Human Genome Sciences Inc's lupus drug is poised to win U.S. clearance this week, offering patients the first approved treatment option in a half-century and setting the company up for blockbuster sales.Industry analysts widely expect Benlysta, one the most ...

At the end of a day of often emotional testimony, an FDA advisory panel overwhelmingly voted to recommend the approval of a new drug for the treatment of systemic lupus.. ?It has a weak effect, but they made the case,? panelist Matthew ...

FDA panel favors lupus drug from Human Genome Sciences despite mixed results in studiesFederal health experts on Tuesday voted in favor of the first new drug to treat Lupus in over 50 years, setting aside concerns that the experimental therapy does not ...

WASHINGTON (Reuters) - A long-awaited lupus drug from Human Genome Sciences Inc faces questions on Tuesday as U.S. advisers debate if the medicine helps patients enough to justify potential side effects.The drug, Benlysta, could be the first medicine cleared for fighting the ...

Previous

1
2
3
4
5

Topic: Human Genome Sciences Inc.

Top UK court backs patent linked to HGS, GSK drug

GSK, HGS lupus drug wins green light in Europe

GSK and HGS lupus drug wins green light in Europe

New lupus drug may end treatment nightmare for some

Big Human Genome lupus drug nears market

Big Human Genome lupus drug nears U.S. market

FDA Advisory Panel Backs New Lupus Drug Benlysta

FDA panel backs first new lupus drug in 50 years

Questions hang over Human Genome lupus drug in U.S.

Questions hang over Human Genome lupus drug in US

From Around the Web

Video Gallery

Follow this Topic with...